{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:27:37Z","timestamp":1775507257950,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T00:00:00Z","timestamp":1247529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T00:00:00Z","timestamp":1247529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s11904-009-0022-z","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T05:55:02Z","timestamp":1247464502000},"page":"162-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Management of patients with the immune reconstitution inflammatory syndrome"],"prefix":"10.1007","volume":"6","author":[{"given":"Suzaan","family":"Marais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique J.","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,14]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/595006","volume":"48","author":"M.A. French","year":"2009","unstructured":"French MA: HIV\/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009, 48:101\u2013107.","journal-title":"Clin Infect Dis"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1479-5876-5-50","volume":"5","author":"J.T. Riddell","year":"2007","unstructured":"Riddell JT, Kaul DR, Karakousis PC, et al.: Mycobacterium avium complex immune reconstitution inflammatory syndrome: long term outcomes. J Transl Med 2007, 5:50.","journal-title":"J Transl Med"},{"key":"22_CR3","first-page":"1282","volume":"11","author":"W. Burman","year":"2007","unstructured":"Burman W, Weis S, Vernon A, et al.: Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis 2007, 11:1282\u20131289.","journal-title":"Int J Tuberc Lung Dis"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/596764","volume":"48","author":"G. Meintjes","year":"2009","unstructured":"Meintjes G, Rangaka MX, Maartens G, et al.: Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis 2009, 48:667\u2013676.","journal-title":"Clin Infect Dis"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1086\/507895","volume":"43","author":"T. Bicanic","year":"2006","unstructured":"Bicanic T, Harrison T, Niepieklo A, et al.: Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis 2006, 43:1069\u20131073.","journal-title":"Clin Infect Dis"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/421386","volume":"39","author":"A. Drake","year":"2004","unstructured":"Drake A, Mijch A, Sasadeusz J: Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART. Clin Infect Dis 2004, 39:129\u2013132.","journal-title":"Clin Infect Dis"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1097\/QAD.0b013e3280110aef","volume":"20","author":"J.V. Baker","year":"2006","unstructured":"Baker JV, Boulware DR, Bohjanen PR: A case for treating high hepatitis B DNA levels before starting HIV therapy. AIDS 2006, 20:2402\u20132403.","journal-title":"AIDS"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/sti.2005.017863","volume":"82","author":"C. Hardwick","year":"2006","unstructured":"Hardwick C, White D, Morris E, et al.: Montelukast in the treatment of HIV associated immune reconstitution disease. Sex Transm Infect 2006, 82:513\u2013514.","journal-title":"Sex Transm Infect"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1586\/14787210.4.3.469","volume":"4","author":"E. Lesho","year":"2006","unstructured":"Lesho E: Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome. Expert Rev Anti Infect Ther 2006, 4:469\u2013478.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/archinte.168.10.1034","volume":"168","author":"S. McGee","year":"2008","unstructured":"McGee S, Hirschmann J: Use of corticosteroids in treating infectious diseases. Arch Intern Med 2008, 168:1034\u20131046.","journal-title":"Arch Intern Med"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","volume":"5","author":"S.D. Lawn","year":"2005","unstructured":"Lawn SD, Bekker LG, Miller RF: Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005, 5:361\u2013373.","journal-title":"Lancet Infect Dis"},{"key":"22_CR12","unstructured":"Meintjes G, Wilkinson RJ, Morroni C, et al.: Randomized placebo-controlled trial of prednisone for the TB immune reconstitution inflammatory syndrome [abstract 34]. Presented at the 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; February 8\u201311, 2009."},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1086\/598988","volume":"48","author":"D.J. Pepper","year":"2009","unstructured":"Pepper DJ, Marais S, Maartens G, et al.: Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009, 48:e96\u2013e107.","journal-title":"Clin Infect Dis"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1212\/01.wnl.0000343510.08643.74","volume":"72","author":"K. Tan","year":"2009","unstructured":"Tan K, Roda R, Ostrow L, et al.: PML-IRIS in patients with HIV infection. Clinical manifestations and treatment with steroids. Neurology 2009, 72:1458\u20131464.","journal-title":"Neurology"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.crad.2006.04.007","volume":"61","author":"G. Rajeswaran","year":"2006","unstructured":"Rajeswaran G, Becker JL, Michailidis C, et al.: The radiology of IRIS (immune reconstitution inflammatory syndrome) in patients with mycobacterial tuberculosis and HIV co-infection: appearances in 11 patients. Clin Radiol 2006, 61:833\u2013843.","journal-title":"Clin Radiol"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/apc.2006.0121","volume":"21","author":"F.F. Tuon","year":"2007","unstructured":"Tuon FF, Mulatti GC, Pinto WP, et al.: Immune reconstitution inflammatory syndrome associated with disseminated mycobacterial infection in patients with AIDS. AIDS Patient Care STDS 2007, 21:527\u2013532.","journal-title":"AIDS Patient Care STDS"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/QAD.0b013e328011981a","volume":"21","author":"J. Dautremer","year":"2007","unstructured":"Dautremer J, Pacanowski J, Girard PM, et al.: A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis. AIDS 2007, 21:381\u2013382.","journal-title":"AIDS"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","volume":"19","author":"O. Lortholary","year":"2005","unstructured":"Lortholary O, Fontanet A, Memain N, et al.: Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005, 19:1043\u20131049.","journal-title":"AIDS"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","volume":"81","author":"S.A. Shelburne 3rd","year":"2002","unstructured":"Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al.: Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002, 81:213\u2013227.","journal-title":"Medicine (Baltimore)"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/00002030-200405210-00021","volume":"18","author":"B.M. Clark","year":"2004","unstructured":"Clark BM, Krueger RG, Price P, French MA: Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis. AIDS 2004, 18:1218\u20131221.","journal-title":"AIDS"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/01.WNL.0000068530.40131.D2","volume":"61","author":"C.J. Sumner","year":"2003","unstructured":"Sumner CJ, Newman M, Jay CA: Recurrent myelopathy after HAART in a patient with spinal mycobacterial infection. Neurology 2003, 61:139\u2013140.","journal-title":"Neurology"},{"issue":"Suppl3","key":"22_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/13550280500511741","volume":"11","author":"F. Gray","year":"2005","unstructured":"Gray F, Bazille C, Adle-Biassette H, et al.: Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 2005, 11(Suppl 3):16\u201322.","journal-title":"J Neurovirol"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/brain\/awh215","volume":"127","author":"R.A. Du Pasquier","year":"2004","unstructured":"Du Pasquier RA, Kuroda MJ, Zheng Y, et al.: A prospective study demonstrates an association between JC virusspecific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004, 127:1970\u20131978.","journal-title":"Brain"},{"issue":"Suppl1","key":"22_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/713831411","volume":"9","author":"R.A. Du Pasquier","year":"2003","unstructured":"Du Pasquier RA, Koralnik IJ: Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?\n                           J Neurovirol 2003, 9(Suppl 1):25\u201331.","journal-title":"J Neurovirol"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/01.aids.0000196175.88421.eb","volume":"20","author":"M.T. Silva","year":"2006","unstructured":"Silva MT, Pacheco MC Jr, Vaz B: Inflammatory progressive multifocal leukoencephalopathy after antiretroviral treatment. AIDS 2006, 20:469\u2013471.","journal-title":"AIDS"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1212\/01.wnl.0000343735.44983.5e","volume":"72","author":"J.R. Berger","year":"2009","unstructured":"Berger JR: Steroids for PML-IRIS. A double-edged sword?\n                           Neurology 2009, 72:1454\u20131455.","journal-title":"Neurology"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/bjo.83.5.540","volume":"83","author":"H.W. Henderson","year":"1999","unstructured":"Henderson HW, Mitchell SM: Treatment of immune recovery vitritis with local steroids. Br J Ophthalmol 1999, 83:540\u2013545.","journal-title":"Br J Ophthalmol"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archopht.116.2.169","volume":"116","author":"M.P. Karavellas","year":"1998","unstructured":"Karavellas MP, Lowder CY, Macdonald C, et al.: Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998, 116:169\u2013175.","journal-title":"Arch Ophthalmol"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","volume":"46","author":"Y.C. Manabe","year":"2007","unstructured":"Manabe YC, Campbell JD, Sydnor E, Moore RD: Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007, 46:456\u2013462.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00002030-200102160-00004","volume":"15","author":"G.A. McComsey","year":"2001","unstructured":"McComsey GA, Whalen CC, Mawhorter SD, et al.: Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS 2001, 15:321\u2013327.","journal-title":"AIDS"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/422257","volume":"190","author":"A.M. Elliott","year":"2004","unstructured":"Elliott AM, Luzze H, Quigley MA, et al.: A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis 2004, 190:869\u2013878.","journal-title":"J Infect Dis"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1212\/01.wnl.0000227922.22293.93","volume":"67","author":"A. Venkataramana","year":"2006","unstructured":"Venkataramana A, Pardo CA, McArthur JC, et al.: Immune reconstitution inflammatory syndrome in the CNS of HIVinfected patients. Neurology 2006, 67:383\u2013388.","journal-title":"Neurology"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/QAD.0b013e3282f4f223","volume":"22","author":"P.F. Volkow","year":"2008","unstructured":"Volkow PF, Cornejo P, Zinser JW, et al.: Life-threatening exacerbation of Kaposi\u2019s sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome. AIDS 2008, 22:663\u2013665.","journal-title":"AIDS"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1080\/00365540260348644","volume":"34","author":"L. Dalessandro","year":"2002","unstructured":"Dalessandro L, Bottaro E: Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis 2002, 34:780\u2013782.","journal-title":"Scand J Infect Dis"},{"key":"22_CR35","unstructured":"AIDS Info: Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Available at http:\/\/AIDSinfo.nih.gov. Accessed April 2009."},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0036-46652002000200011","volume":"44","author":"G.C. Fernandes","year":"2002","unstructured":"Fernandes GC, Vieira MA, Lourenco MC, et al.: Inflammatory paradoxical reaction occurring in tuberculosis patients treated with HAART and rifampicin. Rev Inst Med Trop Sao Paulo 2002, 44:113\u2013114.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1086\/315328","volume":"181","author":"L.G. Bekker","year":"2000","unstructured":"Bekker LG, Haslett P, Maartens G, et al.: Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. J Infect Dis 2000, 181:954\u2013965.","journal-title":"J Infect Dis"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/088307380401900402","volume":"19","author":"J.F. Schoeman","year":"2004","unstructured":"Schoeman JF, Springer P, van Rensburg AJ, et al.: Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol 2004, 19:250\u2013257.","journal-title":"J Child Neurol"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/08830738060210040801","volume":"21","author":"J.F. Schoeman","year":"2006","unstructured":"Schoeman JF, Fieggen G, Seller N, et al.: Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J Child Neurol 2006, 21:301\u2013308.","journal-title":"J Child Neurol"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0163-4453(03)00077-X","volume":"47","author":"M.T. Roberts","year":"2003","unstructured":"Roberts MT, Mendelson M, Meyer P, et al.: The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports. J Infect 2003, 47:251\u2013255.","journal-title":"J Infect"},{"key":"22_CR41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5694\/j.1326-5377.1998.tb123372.x","volume":"169","author":"M. John","year":"1998","unstructured":"John M, French MA: Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med J Aust 1998, 169:473\u2013474.","journal-title":"Med J Aust"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1097\/01.aids.0000191228.36797.5b","volume":"19","author":"H.C. Bell","year":"2005","unstructured":"Bell HC, Heath CH, French MA: Pulmonary Mycobacterium celatum immune restoration disease: immunopathology and response to corticosteroid therapy. AIDS 2005, 19:2047\u20132049.","journal-title":"AIDS"},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1086\/314528","volume":"178","author":"R.S. Wallis","year":"1998","unstructured":"Wallis RS, Johnson JL, Okwera A, et al.: Pentoxifylline in human immunodeficiency virus-positive tuberculosis: safety at 4 years. J Infect Dis 1998, 178:1861.","journal-title":"J Infect Dis"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/00002030-200405210-00023","volume":"18","author":"J.R. Boelaert","year":"2004","unstructured":"Boelaert JR, Goddeeris KH, Vanopdenbosch LJ, Casselman JW: Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy. AIDS 2004, 18:1223\u20131224.","journal-title":"AIDS"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/QAD.0b013e328011cb38","volume":"21","author":"M.C. Lipman","year":"2007","unstructured":"Lipman MC, Carding SK: Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?\n                           AIDS 2007, 21:383\u2013384.","journal-title":"AIDS"},{"key":"22_CR46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4049\/jimmunol.174.2.589","volume":"174","author":"M. Peters-Golden","year":"2005","unstructured":"Peters-Golden M, Canetti C, Mancuso P, Coffey MJ: Leukotrienes: underappreciated mediators of innate immune responses. J Immunol 2005, 174:589\u2013594.","journal-title":"J Immunol"},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2165\/00003495-200059040-00015","volume":"59","author":"B. Jarvis","year":"2000","unstructured":"Jarvis B, Markham A: Montelukast: a review of its therapeutic potential in persistent asthma. Drugs 2000, 59:891\u2013928.","journal-title":"Drugs"},{"key":"22_CR48","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1086\/592695","volume":"47","author":"T.K. Blackmore","year":"2008","unstructured":"Blackmore TK, Manning L, Taylor WJ, Wallis RS: Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 2008, 47:e83\u2013e85.","journal-title":"Clin Infect Dis"},{"key":"22_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-8518-3-7","volume":"3","author":"A. Pires","year":"2005","unstructured":"Pires A, Nelson M, Pozniak AL, et al.: Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy. J Immune Based Ther Vaccines 2005, 3:7.","journal-title":"J Immune Based Ther Vaccines"},{"key":"22_CR50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350501000303","volume":"10","author":"C. Michailidis","year":"2005","unstructured":"Michailidis C, Pozniak AL, Mandalia S, et al.: Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir Ther 2005, 10:417\u2013422.","journal-title":"Antivir Ther"},{"key":"22_CR51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00006982-200406000-00007","volume":"24","author":"M.H. El-Bradey","year":"2004","unstructured":"El-Bradey MH, Cheng L, Song MK, et al.: Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach. Retina 2004, 24:376\u2013382.","journal-title":"Retina"},{"key":"22_CR52","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","volume":"23","author":"T. Bicanic","year":"2009","unstructured":"Bicanic T, Brouwer AE, Meintjes G, et al.: Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009, 23:701\u2013706.","journal-title":"AIDS"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-009-0022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-009-0022-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-009-0022-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-009-0022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T09:31:42Z","timestamp":1659087102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-009-0022-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,14]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11904-009-0022-z","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,14]]},"assertion":[{"value":"14 July 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}